{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:37Z","timestamp":1787020717125,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypoparathyroidism (HypoPT) or pseudo-hypoparathyroidism (pseudo-HypoPT) during pregnancy may cause maternal and fetal\/neonatal complications. In this regard, only a few case reports or case series of pregnant or lactating women have been published. The purpose of this study was to describe clinical and biochemical course, pharmacological management, and potential adverse events during pregnancy and post-partum in pregnant women with HypoPT or pseudo-HypoPT. This was a retrospective, observational, multicenter, study involving nine Italian referral centers for endocrine diseases affiliated with the Italian Society of Endocrinology and involved in \u201cHypoparathyroidism Working Group\u201d.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study identified a cohort of 28 women (followed between 2005 and 2018) with HypoPT (n\u2009=\u200925, 84% postsurgical, 16% idiopathic\/autoimmune) and pseudo-HypoPT (n\u2009=\u20093). In HypoPT women, the mean calcium carbonate dose tended to increase gradually from the first to third trimester (+\u200912.6%) in pregnancy. This average increase in the third trimester was significantly greater compared to the pre-pregnancy period (\n                      <jats:italic>p<\/jats:italic>\n                      value\u2009=\u20090.03). However, analyzing the individual cases, in 44% the mean calcium dosage remained unchanged throughout gestation. Mean calcitriol doses tended to increase during pregnancy, with a statistically significant increase between the third trimester and the pre-pregnancy period (\n                      <jats:italic>p<\/jats:italic>\n                      value\u2009=\u20090.02). Nevertheless, analyzing the individual cases, in the third trimester most women with HypoPT (64%) maintained the same dosage of calcitriol compared to the first trimester. Both mean calcium carbonate and calcitriol doses tended to decrease from the third trimester to the post-partum six months. Most identified women (~\u200970%) did not display maternal complications and (~\u200990%) maintained mean serum albumin-corrected total calcium levels within the low-to-mid normal reference range (8.5\u2009\u00b1\u20090.8\u00a0mg\/dl) during pregnancy. The main complications related to pregnancy period included: preterm birth (n\u2009=\u20093 HypoPT women), and history of miscarriages (n\u2009=\u20096 HypoPT women and n\u2009=\u20092 pseudo-HypoPT women).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study shows that mean serum albumin-corrected total calcium levels were carefully monitored during pregnancy and post-pregnancy, with limited evaluation of other biochemical parameters, such as serum phosphate, 24\u00a0h urinary calcium, 25-OH vitamin D, and creatinine clearance. To avoid complications in mothers affected by (HypoPT) or (pseudo-HypoPT) and offspring, intense biochemical, clinical and pharmacological monitoring during pregnancy and breastfeeding is highly recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-021-02053-3","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T16:05:27Z","timestamp":1633881927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study"],"prefix":"10.1186","volume":"16","author":[{"given":"Gemma","family":"Marcucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bondanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Camozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisella","family":"Cianferotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Duradoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Fossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"degli Uberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Fam\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uberto","family":"Pagotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Parri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria Maddalena","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Zatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of \u201cHypoparathyroidism Working Group\u201d affiliated to the Italian Society of Endocrinology (S.I.E.)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"2053_CR1","first-page":"2015","volume":"15","author":"KH Shah","year":"2015","unstructured":"Shah KH, Bhat S, Shetty S, Umakanth S. Hypoparathyroidism in pregnancy. BMJ Case Rep. 2015;15:2015.","journal-title":"BMJ Case Rep"},{"key":"2053_CR2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.00027.2015","volume":"96","author":"CS Kovacs","year":"2016","unstructured":"Kovacs CS. Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery. Physiol Rev. 2016;96 449\u2013547.","journal-title":"Physiol Rev"},{"key":"2053_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ecl.2005.09.004","volume":"35","author":"CS Kovacs","year":"2006","unstructured":"Kovacs CS, Fuleihan GE-H. Calcium and bone disorders during pregnancy and lactation. Endocrinol Metab Clin North Am. 2006;35:21\u201351.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"180","key":"2053_CR4","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1530\/EJE-18-0541","volume":"1","author":"AA Khan","year":"2019","unstructured":"Khan AA, Clarke B, Rejnmark L, Brandi ML. Management of endocrine disease: hypoparathyroidism in pregnancy: review and evidence based recommendations for management. Eur J Endocrinol. 2019;1(180):R37\u201344.","journal-title":"Eur J Endocrinol"},{"key":"2053_CR5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1172\/JCI107764","volume":"54","author":"L David","year":"1974","unstructured":"David L, Anast CS. Calcium metabolism in newborn infants. The interrelationship of parathyroid function and calcium, magnesium, and phosphorus metabolism in normal, sick, and hypocalcemic newborns. J Clin Invest. 1974;54:287\u201396.","journal-title":"J Clin Invest"},{"key":"2053_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1542\/peds.66.1.77","volume":"66","author":"RM Pitkin","year":"1980","unstructured":"Pitkin RM, Cruikshank DP, Schauberger CW, Reynolds WA, Williams GA, Hargis GK. Fetal calcitropic hormones and neonatal calcium homeostasis. Pediatrics. 1980;66:77\u201382.","journal-title":"Pediatrics"},{"key":"2053_CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1152\/ajplegacy.1967.213.2.363","volume":"213","author":"M Delivoria-Papadopoulos","year":"1967","unstructured":"Delivoria-Papadopoulos M, Battaglia FC, Bruns PD, Meschia G. Total, protein-bound, and ultrafilterable calcium in maternal and fetal plasmas. Am J Physiol. 1967;213:363\u20136.","journal-title":"Am J Physiol"},{"key":"2053_CR8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0022-3476(80)80030-8","volume":"97","author":"AR Fleischman","year":"1980","unstructured":"Fleischman AR, Rosen JF, Cole J, Smith CM, DeLuca HF. Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term. J Pediatr. 1980;97:640\u20132.","journal-title":"J Pediatr"},{"key":"2053_CR9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM198002073020603","volume":"302","author":"JJ Steichen","year":"1980","unstructured":"Steichen JJ, Tsang RC, Gratton TL, Hamstra A, DeLuca HF. Vitamin D homeostasis in the perinatal period: 1,25-dihydroxyvitamin D in maternal, cord, and neonatal blood. N Engl J Med. 1980;302:315\u20139.","journal-title":"N Engl J Med"},{"key":"2053_CR10","first-page":"E385","volume":"239","author":"P Wieland","year":"1980","unstructured":"Wieland P, Fischer JA, Trechsel U, Roth HR, Vetter K, Schneider H, Huch A. Perinatal parathyroid hormone, vitamin D metabolites, and calcitonin in man. Am J Physiol. 1980;239:E385\u201390.","journal-title":"Am J Physiol"},{"key":"2053_CR11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/adc.60.2.110","volume":"60","author":"J Allgrove","year":"1985","unstructured":"Allgrove J, Adami S, Manning RM, O\u2019Riordan JL. Cytochemical bioassay of parathyroid hormone in maternal and cord blood. Arch Dis Child. 1985;60:110\u20135.","journal-title":"Arch Dis Child"},{"key":"2053_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1203\/00006450-199102000-00020","volume":"29","author":"LP Rubin","year":"1991","unstructured":"Rubin LP, Posillico JT, Anast CS, Brown EM. Circulating levels of biologically active and immunoreactive intact parathyroid hormone in human newborns. Pediatric Res. 1991;29:201\u20137.","journal-title":"Pediatric Res"},{"key":"2053_CR13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1530\/eje.0.1390284","volume":"139","author":"F Callies","year":"1998","unstructured":"Callies F, Arlt W, Scholz HJ, Reincke M, Allolio B. Management of hypoparathyroidism during pregnancy\u2014report of twelve cases. Eur J Endocrinol. 1998;139:284\u20139.","journal-title":"Eur J Endocrinol"},{"key":"2053_CR14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.291.6500.955","volume":"291","author":"R Eastell","year":"1985","unstructured":"Eastell R, Edmonds CJ, De Chayal RC, McFadyen IR. Prolonged hypoparathyroidism presenting eventually as second trimester abortion. Br Med J (Clin Res Ed). 1985;291:955\u20136.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2053_CR15","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-18-0609","volume":"180","author":"AA Khan","year":"2018","unstructured":"Khan AA, Koch C, Van Uum SHM, Baillargeon JP, Bollerslev J, Brandi ML, Marcocci C, Rejnmark L, Rizzoli R, Shrayyef MZ, et al. Standards of care for hypoparathyroidism in adults. Eur J Endocrinol. 2018;180:P1\u201322.","journal-title":"Eur J Endocrinol"},{"key":"2053_CR16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000491046","volume":"51","author":"G Marcucci","year":"2019","unstructured":"Marcucci G, Brandi ML. Conventional treatment of hypoparathyroidism. Front Horm Res. 2019;51:160\u20134.","journal-title":"Front Horm Res"},{"key":"2053_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bonr.2015.05.005","volume":"30","author":"BL Hatswell","year":"2015","unstructured":"Hatswell BL, Allan CA, Teng J, Wong P, Ebeling PR, Wallace EM, Fuller PJ, Milat F. Management of hypoparathyroidism in pregnancy and lactation\u2014a report of 10 cases. Bone Rep. 2015;30:15\u20139.","journal-title":"Bone Rep"},{"key":"2053_CR18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","volume":"14","author":"G Mantovani","year":"2018","unstructured":"Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G, et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement. Nat Rev Endocrinol. 2018;14:476\u2013500.","journal-title":"Nat Rev Endocrinol"},{"key":"2053_CR19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4158\/EP09337.CR","volume":"16","author":"LL Sweeney","year":"2010","unstructured":"Sweeney LL, Malabanan AO, Rosen H. Decreased calcitriol requirement during pregnancy and lactation with a window of increased requirement immediately post partum. Endocr Pract. 2010;16:459\u201362.","journal-title":"Endocr Pract"},{"key":"2053_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00223-018-0411-7","volume":"103","author":"G Marcucci","year":"2018","unstructured":"Marcucci G, Cianferotti L, Parri S, Altieri P, Arvat E, Benvenga S, Betterle C, Bondanelli M, Boscaro M, Camozzi V, et al. HypoparaNet: a database of chronic hypoparathyroidism based on expert medical-surgical centers in Italy. Calcif Tissue Int. 2018;103:151\u201363.","journal-title":"Calcif Tissue Int"},{"key":"2053_CR21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40618-014-0202-6","volume":"38","author":"G Marcucci","year":"2015","unstructured":"Marcucci G, Cianferotti L, Beck-Peccoz P, Capezzone M, Cetani F, Colao A, Dav\u00ec MV, Degli Uberti E, Del Prato S, Elisei R, et al. Rare diseases in clinical endocrinology: a taxonomic classification system. J Endocrinol Invest. 2015;38:193\u2013259.","journal-title":"J Endocrinol Invest"},{"key":"2053_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1179\/146532809X440770","volume":"29","author":"N Demirel","year":"2009","unstructured":"Demirel N, Aydin M, Zenciroglu A, Okumus N, Cetinkaya S, Yildiz YT, Ipek MS. Hyperparathyroidism secondary to maternal hypoparathyroidism and vitamin D deficiency: an uncommon cause of neonatal respiratory distress. Ann Trop Paediatr. 2009;29:149\u201354.","journal-title":"Ann Trop Paediatr"},{"issue":"27","key":"2053_CR23","first-page":"8316017","volume":"2018","author":"CG Richa","year":"2018","unstructured":"Richa CG, Issa AI, Echtay AS, El Rawas MS. Idiopathic hypoparathyroidism and severe hypocalcemia in pregnancy. Case Rep Endocrinol. 2018;2018(27):8316017.","journal-title":"Case Rep Endocrinol"},{"key":"2053_CR24","first-page":"2017","volume":"26","author":"J Dixon","year":"2018","unstructured":"Dixon J, Miller S. Successful pregnancies and reduced treatment requirement while breast feeding in a patient with congenital hypoparathyroidism due to homozygous c.68C>A null parathyroid hormone gene mutation. BMJ Case Rep. 2018;26:2017\u2013223811.","journal-title":"BMJ Case Rep"},{"key":"2053_CR25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.12891\/ceog1984.2015","volume":"42","author":"P Bakas","year":"2015","unstructured":"Bakas P, Chados N, Hassiakos D, Creatsa M, Liapis A, Creatsas G. Secondary hypoparathyroidism during pregnancy\u2014a case report and review of the literature. Clin Exp Obstet Gynecol. 2015;42:825\u20136.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"2053_CR26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.14212","volume":"93","author":"EAR Hartogsohn","year":"2020","unstructured":"Hartogsohn EAR, Khan AA, Underbjerg L, Sikjaer T, Hussain S, Rejnmark L. Changes in treatment needs of hypoparathyroidism during pregnancy and lactation: a case series. Clin Endocrinol (Oxf). 2020;93:261\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2053_CR27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3109\/01443615.2013.834302","volume":"3","author":"D Ochiai","year":"2013","unstructured":"Ochiai D, Uchino H, Ikeda T, Yakubo K, Fukuiya T. Pseudohypoparathyroidism type 1a in pregnancy. J Obstet Gynaecol. 2013;3:900.","journal-title":"J Obstet Gynaecol"},{"key":"2053_CR28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/01443615.2016.1250733","volume":"37","author":"P Guedes Ramallo","year":"2017","unstructured":"Guedes Ramallo P, Boix CE. Management of pseudohypoparathyroidism in pregnancy: a case report. J Obstet Gynaecol. 2017;37:519\u201320.","journal-title":"J Obstet Gynaecol"},{"key":"2053_CR29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000010122","volume":"47","author":"K Seki","year":"1999","unstructured":"Seki K, Osada H, Yasuda T, Sekiya S. Pseudohypoparathyroidism type 1b in pregnancy. Gynecol Obstet Invest. 1999;47:278\u201380.","journal-title":"Gynecol Obstet Invest"},{"key":"2053_CR30","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3109\/01443615.2013.834302","volume":"33","author":"D Ochiai","year":"2013","unstructured":"Ochiai D, Uchino H, Ikeda T, Yakubo K, Fukuiya T. Pseudohypoparathyroidism type 1a in pregnancy. J Obstet Gynaecol. 2013;33:900.","journal-title":"J Obstet Gynaecol"},{"key":"2053_CR31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.beem.2018.07.001","volume":"32","author":"L Cianferotti","year":"2018","unstructured":"Cianferotti L, Marcucci G, Brandi ML. Causes and pathophysiology of hypoparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32:909\u201325.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2053_CR32","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, J\u00fcppner H, D\u2019Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26:2317\u201337.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2053_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MED.0b013e328334f041","volume":"17","author":"DM Mitchell","year":"2010","unstructured":"Mitchell DM, J\u00fcppner H. Regulation of calcium homeostasis and bone metabolism in the fetus and neonate. Curr Opin Endocrinol Diabetes Obes. 2010;17(1):25\u201330.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2053_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3835(00)00697-2","volume":"163","author":"O Gimm","year":"2001","unstructured":"Gimm O. Thyroid cancer. Cancer Lett. 2001;163:143\u201356.","journal-title":"Cancer Lett"},{"issue":"38","key":"2053_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2169\/internalmedicine.38.75","volume":"1999","author":"N Kaneko","year":"1999","unstructured":"Kaneko N, Kaneko S, Yamada S, Suzuki K, Ohyama Y, Nakagawa O, Tani N, Aizawa Y. Untreated idiopathic hypoparathyroidism associated with infant congenital and perinatal abnormalities. Intern Med. 1999;1999(38):75.","journal-title":"Intern Med"},{"key":"2053_CR36","first-page":"629583","volume":"012","author":"A Singh","year":"2012","unstructured":"Singh A, Agarwal N, Chopra S, Sikka P, Suri V, Kumar B, Dutta P. Management of pseudohypoparathyroidism type 1a during pregnancy and labor: a case report. Case Rep Obstet Gynecol. 2012;012:629583.","journal-title":"Case Rep Obstet Gynecol"},{"key":"2053_CR37","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1210\/jcem-52-4-810","volume":"52","author":"BL Salle","year":"1981","unstructured":"Salle BL, Berthezene F, Glorieux FH, Delvin EE, Berland M, David L, Varenne JP, Putet G. Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metab. 1981;52:810\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"2053_CR38","first-page":"254","volume":"243","author":"A Sadeghi-Nejad","year":"1980","unstructured":"Sadeghi-Nejad A, Wolfsdorf J, Senior B. Hypoparathyroidism and pregnancy. Treatment with calcitriol JAMA. 1980;243:254\u20135.","journal-title":"Treatment with calcitriol JAMA"},{"issue":"3 Pt 2","key":"2053_CR39","first-page":"485","volume":"6","author":"RH Caplan","year":"1990","unstructured":"Caplan RH, Beguin EA. Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation. Obstet Gynecol. 1990;6(3 Pt 2):485\u20139.","journal-title":"Obstet Gynecol"},{"key":"2053_CR40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/09513590.2010.507284","volume":"27","author":"R Krysiak","year":"2011","unstructured":"Krysiak R, Kobielusz-Gembala I, Okopien B. Hypoparathyroidism in pregnancy. Gynecol Endocrinol. 2011;27:529\u201332.","journal-title":"Gynecol Endocrinol"},{"issue":"85","key":"2053_CR41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0002-9378(16)35361-3","volume":"1","author":"ET Turner","year":"1963","unstructured":"Turner ET, Freier AA. Hypoparathyroidism and pregnancy. Am J Obstet Gynecol. 1963;1(85):133\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2053_CR42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0002-9378(73)90627-3","volume":"117","author":"J Bolen","year":"1973","unstructured":"Bolen J. Hypoparathyroidism in pregnancy. Am J Obstet Gynecol. 1973;117(2):178\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"2053_CR43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1507\/endocrj1954.31.227","volume":"3","author":"RL Rude","year":"1984","unstructured":"Rude RL, Haussler MR, Singer FR. Postpartum resolution of hypocalcaemia in a lactating hypoparathyroid patient. Endocrinol Jpn. 1984;3:227\u201333.","journal-title":"Endocrinol Jpn"},{"issue":"1","key":"2053_CR44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.1.5635.23","volume":"4","author":"AD Wright","year":"1969","unstructured":"Wright AD, Joplin GF, Dixon HG. Post-partum hypercalcaemia in treated hypoparathyroidism. Br Med J. 1969;4(1):23\u20135.","journal-title":"Br Med J"},{"key":"2053_CR45","first-page":"50","volume":"8","author":"OM Al Nozha","year":"2013","unstructured":"Al Nozha OM, Malekzadeh-Shirvani P. Calcium homeostasis in a patient with hypoparathyroidism during pregnancy, lactation and menstruation. J Taibah Univ Med Sci. 2013;8:50\u20133.","journal-title":"J Taibah Univ Med Sci"},{"key":"2053_CR46","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","volume":"97","author":"DM Mitchell","year":"2012","unstructured":"Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, Burnett-Bowie SA, Mannstadt M. Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab. 2012;97:4507\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"2053_CR47","first-page":"205","volume":"55","author":"CL Smith","year":"2001","unstructured":"Smith CL, Kristensen C, Davis M, Abraham PA. An evaluation of the physicochemical risk for renal stone disease during pregnancy. Clin Nephrol. 2001;55:205\u201311.","journal-title":"Clin Nephrol"},{"key":"2053_CR48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00240-006-0051-7","volume":"34","author":"R Sefa","year":"2006","unstructured":"Sefa R, Cetin EH, Gurkan K, Metin K. Are changes in urinary parameters during pregnancy clinically significant? Urol Res. 2006;34:244\u20138.","journal-title":"Urol Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02053-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02053-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02053-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T11:50:46Z","timestamp":1673437846000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02053-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2053"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02053-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-101209\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"29 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board (Comitato Etico Area Vasta Centro, AUOC, Florence, Italy) [number: 10641_oss; 16 May 2017]. Informed consent was collected in accordance with General Authorization to Process Personal Data for Scientific Research Purposes (Authorization no. 9\/2013, The Italian Data Protection Authority). The study was conducted according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual person\u2019s data in any form. All data were analyzed anonymously and published exclusively as aggregates.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflict of interest. This is a non-profit study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}